PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC12972984::ACT039569

MAVP

Evidence text

Paper-level observation

parallel assays using PC12 neural cells revealed no significant impairment of migration by MAVP treatment, demonstrating selective action on endothelial cells (Fig. S1).
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Cytotoxic
Measure
percent_inhibition
Comparator
=
Raw observation
no significant impairment of migration by MAVP treatment
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
PC12
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.